Your search returned 9 results.

Results
	1.	Intact 5HT neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline. [electronic resource] by Clements-Jewery, S Robson, P A Producer: 19821202 In: Neuropharmacology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists. [electronic resource] by Clements-Jewery, S Robson, P A Producer: 19801024 In: Neuropharmacology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions? [electronic resource] by Clements-Jewery, S Robson, P A Producer: 19820313 In: Neuropharmacology vol. 20 Availability: No items available. Save to lists Add to cart (remove)
	4.	Biochemical investigations into the mode of action of trazodone. [electronic resource] by Clements-Jewery, S Robson, P A Chidley, L J Producer: 19810226 In: Neuropharmacology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Comparison of a new method for computer analysis with standard techniques for measuring survival rates in the rat transverse rectus abdominis musculocutaneous flap. [electronic resource] by Sano, K Hallock, G G Wasser, T E Robson, P A Rice, D C Producer: 20020416 In: Annals of plastic surgery vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs. [electronic resource] by Curnock, A P Robson, P A Yea, C M Moss, D Gadher, S Thomson, T A Westwood, R Ruuth, E Williamson, R A Producer: 19970807 In: The Journal of pharmacology and experimental therapeutics vol. 282 Availability: No items available. Save to lists Add to cart (remove)
	7.	Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. [electronic resource] by Bruneau, J M Yea, C M Spinella-Jaegle, S Fudali, C Woodward, K Robson, P A Sautès, C Westwood, R Kuo, E A Williamson, R A Ruuth, E Producer: 19990126 In: The Biochemical journal vol. 336 ( Pt 2) Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. [electronic resource] by Williamson, R A Yea, C M Robson, P A Curnock, A P Gadher, S Hambleton, A B Woodward, K Bruneau, J M Hambleton, P Spinella-Jaegle, S Morand, P Courtin, O Sautés, C Westwood, R Hercend, T Kuo, E A Ruuth, E Producer: 19970121 In: Transplantation proceedings vol. 28 Availability: No items available. Save to lists Add to cart (remove)
	9.	Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. [electronic resource] by Williamson, R A Yea, C M Robson, P A Curnock, A P Gadher, S Hambleton, A B Woodward, K Bruneau, J M Hambleton, P Moss, D Thomson, T A Spinella-Jaegle, S Morand, P Courtin, O Sautés, C Westwood, R Hercend, T Kuo, E A Ruuth, E Producer: 19951017 In: The Journal of biological chemistry vol. 270 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)